[Pharmacological, pharmacokinetic, and clinical profile of palonosetron hydrochloride (ALOXI I.V. Injection 0.75 mg), a novel antiemetic 5-HT3-receptor antagonist].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples